1AI 16.7% 0.7¢ algorae pharmaceuticals limited

New High, page-101

  1. 10 Posts.
    The more I research and hear about this company and its technology the better it gets. Yes the initial trials involve PD but clearly those involved are excited about there being potential to effectively treat otherwise intractable, fatal neurological disease such as Huntingtons Chorea. Thanks NZ Trader for pointing out the 2 slides at the begining of Barry Snows talk to the Parkinsons Society contrasting the brain scans of an animal model with Huntingtons with and without their treatment (presumably using the same cells as they are implanting for Parkinsons).
    This could be a "silver bullet"!
    I recall a previous post where someone commented that passing this one up would leave you feeling like the record company exec. who failed to sign up the Rolling Stones.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.